TheStreet home
TheStreet home
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Alicia McElhaney

Articles From This Author

Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

Neurocrine Biosciences Leads Pre-Market Biotech Movers

Mylan Falls on FDA Warning on Quality Control
STOCKS

Mylan Falls on FDA Warning on Quality Control

French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal
STOCKS

Biotech Movers Trading Positive Ahead of Market's Open

Medivation Founder Takes Helm at Axovant, Shares Spike
STOCKS

Medivation Founder Takes Helm at Axovant, Shares Spike

French Authorities Suspend AB Science Clinical Trials, Days Before ALS Drug Data Reveal
STOCKS

Endo international, AngioDynamics Lead Biotech Movers

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely
MERGERS AND ACQUISITIONS

Dollar Store Debacle Bodes Poorly for Walgreens-Rite Aid Merger

Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

Trevena, Synergy Lead Biotech Movers

Valeant Shares Dive on Reports of New Debt
STOCKS

Valeant Shares Close Below $10 for First Time Since 2008

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO
STOCKS

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO

Immunomedics, Mylan Lead Biotech Movers
STOCKS

Mylan Expands EpiPen Recall

The 'Dogs' of Wall Street: Here's a Look at Some of the Worst Performing Stocks of the Year
MERGERS AND ACQUISITIONS

After Clearing Valeant Litigation, Jaguar and Napo Pharmaceuticals Reunite

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals
HEALTH

Here Are Some of the Top Healthcare Stocks in the First Quarter

Ackman Reflects on His Valeant Investment
INVESTING

Ackman Reflects on His Valeant Investment

Ackman Says Latest Investment Up 30% Since Fund Took Stake
STOCKS

Ackman Says He's Sorry For Valeant Investment

Mylan Falls on FDA Warning on Quality Control
STOCKS

FDA Rejection of Mylan Generic Adds to Its Woes

Here's Why Valeant's Stock Had Another Disastrous Week
STOCKS

Valeant's Banks Extend a Lifeline

Despite Settling Decade-Long Suit, Mylan Shares Fall
STOCKS

Mylan Hires Former SEC Commissioner for Chief Legal Officer Position

Former Valeant CEO Files Suit Against the Company
STOCKS

Former Valeant CEO Files Suit Against the Company

Why the AHCA Has Already Failed
STOCKS

Impax Gains 38% On CEO Appointment, Talk of Sale

Acorda Therapeutics Sinks on Invalidated Patents
STOCKS

Skincare Makers Lead Biotech Movers

Immunomedics, Mylan Lead Biotech Movers
MERGERS AND ACQUISITIONS

Mylan Hit After Abbott Dumps Shares

Tenet Shares Drop as First Quarter Guidance Sinks
STOCKS

Here's How to Invest in Hospital Stocks Ahead of AHCA Vote

Immunomedics, Mylan Lead Biotech Movers
STOCKS

Immunomedics, Mylan Lead Biotech Movers

Hikma Shakes Up U.S. Operations After FDA Disappointment; CEO Said Darwazah to Lead Group
MERGERS AND ACQUISITIONS

A Deal is Imminent For Depomed, CFO Says

Valeant Shares Dive on Reports of New Debt
STOCKS

Valeant CEO Compensation Revealed, Shares Climb

Valeant's Downtrends Are Still Intact
STOCKS

Valeant Slumps on Refinancing Completion

FTC Approves Abbott's Acquisition of Alere, Stock Jumps
MERGERS AND ACQUISITIONS

Can Abbott Outperform Despite Alere?

Acorda Therapeutics Sinks on Invalidated Patents
STOCKS

Regenxbio Leads Biotech Movers Ahead of Market's Open

Mylan's Government Connections Go Deeper Than Initially Reported
REGULATION

Mylan's Government Connections Go Deeper Than Initially Believed

Acorda Therapeutics Sinks on Invalidated Patents
STOCKS

CytomX Soars on Bristol-Myers Partnership

New Fred's Directors Seek To Send Message to FTC
MERGERS AND ACQUISITIONS

Fred's Appoints Retail-Focused Board Members As Walgreens and Rite Aid Near FTC Approval

Here's Why Valeant's Stock Had Another Disastrous Week
STOCKS

Valeant Shares Skyrocket After Hours on ValueAct Buy

Insys Falls on Earnings Delay
STOCKS

Insys Falls on Earnings Delay

Health Care Investors Attempt to Parse Trump Budget
STOCKS

Health Care Investors Attempt to Parse Trump Budget

Valeant's Downtrends Are Still Intact
STOCKS

Valeant Shares Still Reeling From Ackman Exit

Shanda Goes Active on Community Health
STOCKS

Shanda Goes Active on Community Health

Here's Why Valeant's Stock Had Another Disastrous Week
STOCKS

Here's Why Valeant Struggled This Week

Incyte Pops on Continued Gilead Takeout Speculation
STOCKS

Incyte Pops on Continued Gilead Takeout Speculation

Jazz Pharma, CoLucid Spike Premarket, Plus Other Biotech Movers
STOCKS

Immunomedics Soars on Injunction Against Seattle Genetics Deal

Valeant's Downtrends Are Still Intact
STOCKS

Valeant Launches Loan Offering Days After Paying Down $1.1 Billion in Debt

Sanofi Sues Mylan Over EpiPen Practices
STOCKS

Politicians Question EpiPen Competitor Auvi-Q's High Pricetag

Kraft Heinz Takes a Page From Weight Watchers, Inks Oprah for Product Line
STOCKS

Here's Why Weight Watchers' New CEO Should Be a Woman

Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO
STOCKS

Valeant Plummets for Second Day

Valeant Shares Dive on Reports of New Debt
STOCKS

Valeant Shares Fall on Reports of New Debt

Mylan's Government Connections Go Deeper Than Initially Reported
CORPORATE GOVERNANCE

Can Mylan Shake Specter of Poor Corporate Governance?

FDA Decision on Novartis Gene Therapy Drug Could Benefit Kite Pharma
MERGERS AND ACQUISITIONS

Kite Completes Additional Public Offering

Mylan's Government Connections Go Deeper Than Initially Reported
STOCKS

Twenty More States Accuse Mylan, Teva and Others of Price Collusion

Valeant Shares Dive on Reports of New Debt
STOCKS

Valeant Shares Plummet After Reporting 13% Drop In Sales

Incyte Cancer Immunotherapy Drug Is Object of Desire for Two Big Pharma Rivals
STOCKS

Biotech Movers: Cempra flys high on phase three results

Argos Plummets 72%, Leads Biotech Movers
STOCKS

Biotech movers: Argos plummets 72%